H. Morel

发表

Women and COPD: do we need more evidence?

S. Guillot, C. Raherison, S. Jouneau, 2019, European Respiratory Review.

Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort

F. Goupil, M. Legrand, D. Debieuvre, 2022, Respiratory Medicine and Research.

ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution (TOUPIE): research protocol of a multicentric prospective study

L. Plantier, S. Marchand-Adam, T. Flament, 2021, BMJ Open.

Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer.

B. Asselain, D. Debieuvre, G. Oliviero, 2018, Lung cancer.

[What is the role of non-inhaled drug management in acute COPD exacerbation?]

H. Morel, 2017, Revue des maladies respiratoires.

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Nancy E. Marion, B. Delclaux, B. Asselain, 2022, The Lancet regional health. Europe.

Is Nutritional Screening of Patients with Lung Cancer Optimal? An Expert Opinion Survey of French Physicians and Surgeons

P. Souquet, S. Couraud, J. Péron, 2019, Nutrition and cancer.

[The clinical and economic assessment of surgery in the treatment of the obstructive sleep apnea syndrome. The Working Group assembled by the ANAES. L'Agence Nationale d'Accréditation et d'Evaluation en Santé. A synthesis].

N. Roche, H. Morel, 1999, Revue de Stomatologie et de Chirurgie Maxillo-Faciale.

First-Line Afatinib plus Cetuximab for EGFR-Mutant Non–Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study

O. Molinier, M. Denis, D. Moro-Sibilot, 2021, Clinical Cancer Research.

Comorbidities of COPD

Patrice Diot, Sylvain Marchand-Adam, P. Diot, 2013, European Respiratory Review.

[Massive hemoptysis during sarcoidosis].

S. Qanadli, T. Chinet, S. Labrune, 2000, Revue des maladies respiratoires.

Update on the roles of distal airways in COPD

P. Devillier, A. Didier, N. Roche, 2011, European Respiratory Review.

Clinical practice guidelines: medical follow-up of patients with asthma--adults and adolescents.

N. Roche, P. Godard, H. Morel, 2005, Respiratory medicine.

[Comorbidities of COPD].

P. Diot, F. Goupil, G. Brinchault, 2015, Revue de pneumologie clinique.

[Treatment of distal airways involvement in COPD].

P. Devillier, A. Didier, N. Roche, 2011, Revue des maladies respiratoires.

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

D. Planchard, P. Souquet, F. Bonnetain, 2019, Journal of cachexia, sarcopenia and muscle.

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

E. Blot, P. Ingrand, J. Douillard, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04)

F. Guisier, A. Vergnenègre, P. Dô, 2019, Cancer medicine.

1273P Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the randomized SAFIR02 LUNG-IMMUNO trial

I. Bièche, J. Adam, J. Soria, 2020 .

[Pharmacological treatment optimisation in patients with stale COPD. Position of the French-language Respiratory Society. 2021 Update].

P. Devillier, N. Roche, B. Delclaux, 2021, Revue des maladies respiratoires.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

N. Roche, B. Delclaux, P. Burgel, 2017, Revue des maladies respiratoires.

[Osteochondroplastic tracheobronchopathy: About three cases].

S. Marchand-Adam, F. Arbion, A. Dixmier, 2018, Revue des maladies respiratoires.

Women and COPD do we need more evidence?

S. Guillot, C. Raherison, S. Jouneau, 2020 .